HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q2 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $23,391,000 | +19.2% | 885,000 | -11.9% | 0.01% | 0.0% |
Q4 2018 | $19,627,000 | -1.5% | 1,004,416 | -1.3% | 0.01% | +33.3% |
Q3 2018 | $19,920,000 | +5.7% | 1,017,321 | -10.6% | 0.01% | 0.0% |
Q2 2018 | $18,847,000 | +693.2% | 1,138,116 | +580.1% | 0.01% | +500.0% |
Q1 2018 | $2,376,000 | +26.9% | 167,336 | +30.5% | 0.00% | 0.0% |
Q4 2017 | $1,872,000 | -90.1% | 128,192 | -91.4% | 0.00% | -85.7% |
Q3 2017 | $18,832,000 | -21.8% | 1,485,170 | -26.8% | 0.01% | 0.0% |
Q2 2017 | $24,076,000 | +1172.5% | 2,028,304 | +1484.5% | 0.01% | +600.0% |
Q1 2017 | $1,892,000 | +93.1% | 128,010 | +111.2% | 0.00% | – |
Q4 2016 | $980,000 | -5.9% | 60,601 | +5.6% | 0.00% | – |
Q3 2016 | $1,041,000 | +48.1% | 57,402 | +34.6% | 0.00% | – |
Q2 2016 | $703,000 | +123.9% | 42,651 | +125.1% | 0.00% | – |
Q1 2016 | $314,000 | -93.6% | 18,946 | -86.6% | 0.00% | -100.0% |
Q2 2015 | $4,895,000 | +30.3% | 140,904 | -2.6% | 0.00% | +100.0% |
Q1 2015 | $3,756,000 | – | 144,610 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,609,894 | $109,460,000 | 3.84% |
Avoro Capital Advisors LLC | 5,593,683 | $92,631,000 | 3.57% |
Broadfin Capital, LLC | 1,339,575 | $22,183,000 | 3.49% |
SCOPIA CAPITAL MANAGEMENT LP | 11,912,290 | $197,268,000 | 3.45% |
JW Asset Management, LLC | 270,775 | $4,484,000 | 2.86% |
Rhenman & Partners Asset Management AB | 1,632,212 | $27,029,000 | 2.77% |
Paulson & Co. | 7,670,700 | $127,027,000 | 2.60% |
Redwood Investments, LLC | 1,315,149 | $21,779,000 | 1.50% |
KOPP INVESTMENT ADVISORS LLC | 93,220 | $1,544,000 | 1.45% |
1492 Capital Management LLC | 72,951 | $1,208,000 | 0.86% |